OrbiMed Advisors LLC
- SEC CIK
- 0001055951
- Latest filing
- Aug 14, 2026
RYTM holding history
Rhythm Pharmaceuticals, Inc. in every 13F filed by OrbiMed Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RYTM overviewAll 13F holders of RYTMFull Q2 2026 holdings
- Shares (Q2 2026)
- 322,900
- Value
- $35.9M
- % of portfolio
- 0.7%
- Quarters held
- 12
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 322,900 | $35.9M | 0.7% | +8,800+2.8% | Added | Holders |
| Q1 2026 | 314,100 | $27.3M | 0.6% | +74,300+31.0% | Added | Holders |
| Q4 2025 | 239,800 | $25.7M | 0.5% | +24,648+11.5% | Added | Holders |
| Q3 2025 | 215,152 | $21.7M | 0.5% | −33,360−13.4% | Reduced | Holders |
| Q2 2025 | 248,512 | $15.7M | 0.4% | −131,488−34.6% | Reduced | Holders |
| Q1 2025 | 380,000 | $20.1M | 0.5% | −20,000−5.0% | Reduced | Holders |
| Q4 2024 | 400,000 | $22.4M | 0.5% | −35,900−8.2% | Reduced | Holders |
| Q3 2024 | 435,900 | $22.8M | 0.4% | −268,942−38.2% | Reduced | Holders |
| Q2 2024 | 704,842 | $28.9M | 0.6% | 00.0% | Unchanged | Holders |
| Q1 2024 | 704,842 | $30.5M | 0.6% | +168,200+31.3% | Added | Holders |
| Q4 2023 | 536,642 | $24.7M | 0.5% | −47,000−8.1% | Reduced | Holders |
| Q3 2023 | 583,642 | $13.4M | 0.3% | +583,642 | New | Holders |